Latest Content

At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.

Experts detail evidence for exercise, acupuncture, and mind-body care during radiation, and the knowledge and referral gaps that limit uptake.

The PCR-based tissue assay can now identify patients with MSI-high solid tumors who may be candidates for pembrolizumab.

An 18-year analysis of a foundation program found trial-related travel, lodging, and caregiving costs varied by income, distance, and trial phase.

Coral Omene, MD, PhD, discusses the clinical impact of breast cancer disparities and how oncology nurses can support diverse trial recruitment.

Jessica Miles, MS, RN, CNS, explains how bench testing showed pumps and filters did not compromise stem cell infusion safety.

The oral CSF-1R inhibitor produced a 54% response rate vs 3% with placebo at week 25 in the phase 3 MANEUVER trial.

An ONS review presented at EONS19 outlines 7 system-level employer strategies to curb oncology nurse burnout and improve retention.

Daisy Molina, EdD, MSN, RNC-LRN, discusses listening, honest reassurance, and lifelong communication skills for nurses facing hard conversations.

A Columbia nurse scientist shares her takeaways from the 2026 ASCO Quality Care Symposium, from geriatric assessment to care across the age span.

A patient, a caregiver, nurses, an NP, and an oncologist discuss rash prevention, dose holds, cost, and trial eligibility with oral daraxonrasib.

Daisy Molina, EdD, MSN, RNC-LRN, explains how nurses can include caregivers in breast cancer care while keeping the patient's voice central.

In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.